ADIM
CNXC icon

Alpha DNA Investment Management’s Concentrix CNXC Stock Holding History

Alpha DNA Investment Management’s Portfolio CNXC Stock Details CNXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-9
Closed – – 699
2020
Q4 		$0 Buy
+9
New +$900 ﹤0.01% 596

Other funds holding CNXC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
LAM
Lyrical Asset Management New York $6.56B AUM 20.06% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ABI
Abrams Bison Investments Bethesda, Maryland $2.31B AUM 40.26% 1-Year Est. Return

Alpha DNA Investment Management's CNXC Position: Q1 2021 in Review

Alpha DNA Investment Management sold out of Concentrix (CNXC) in Q1 2021, closing a stake of 9 shares.

Alpha DNA Investment Management first reported a position in CNXC in Q4 2020 and held it in 1 quarter. The position peaked at $0 in Q4 2020. 316 funds tracked by Wall St. Rank hold CNXC as of Q1 2021.

  • Alpha DNA Investment Management reported no remaining Concentrix position as of Q1 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 9 Concentrix shares in Q1 2021.
  • Alpha DNA Investment Management first reported a position in Concentrix in Q4 2020 and held it in 1 quarter.
  • Alpha DNA Investment Management's Concentrix position peaked at $0 in Q4 2020.
  • 316 funds tracked by Wall St. Rank held Concentrix as of Q1 2021.

Based on Alpha DNA Investment Management's 13F filing for Q1 2021, filed 12 May 2021.